Previous 10 | Next 10 |
Twist Bioscience (TWST) and Watchmaker Genomics ink partnership to enable research across a wide range of high throughput sequencing applications including oncology and tumor profiling, inherited disease detection, liquid biopsy assays, and minimal residual disease monitoring. In their first ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throu...
-- Virtual Poster Presentation, Customer Talks, Booth Available -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several events at the virtua...
Twist Bioscience (TWST) announces the launch of its Twist NGS Methylation Detection System, an end-to-end sample preparation and target enrichment solution for identifying methylated regions in the human genome.DNA methylation plays a key role in many biological processes including ...
-- Studying Methylation Patterns Provides Unique Insight into Disease Pathology -- -- System Improves Accuracy of Results, Allows Capture of Customized Genes of Interest, Operational Efficiency -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling custom...
Monday provided growth investors with a nasty wake-up call to start the week. Is this the start of a new trend as we inch toward reopening? The markets lately have provided very small windows in which to purchase the anointed "darlings" and one must be ready with a list and target pri...
Cathie Wood and her team have shown investors that they have the capability to turn double-digit growth dreams into reality. However, the last changes she has brought to ARKG suggest caution in view of a market correction risk. In addition, she remains invested in high-growth name...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Berry Genomics, a leading commercial next-generation sequencing (NGS) provider in China, will add Twis...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscien...
- Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services - Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Serv...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...